HEADER OXIDOREDUCTASE 12-AUG-02 1H2N TITLE FACTOR INHIBITING HIF-1 ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HYPOXIA-INDUCIBLE FACTOR ASPARAGINE HYDROXYLASE, FACTOR COMPND 5 INHIBITING HIF-1, FIH1; COMPND 6 EC: 1.14.11.16; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A(+) KEYWDS TRANSCRIPTION ACTIVATOR, OXIDOREDUCTASE, OXYGENASE, HYPOXIA, KEYWDS 2 HYDROXYLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.ELKINS,K.S.HEWITSON,L.A.MCNEILL,I.SCHLEMMINGER,J.F.SEIBEL, AUTHOR 2 C.J.SCHOFIELD REVDAT 7 08-MAY-24 1H2N 1 REMARK LINK REVDAT 6 21-FEB-18 1H2N 1 JRNL REVDAT 5 13-JUL-11 1H2N 1 VERSN REVDAT 4 22-DEC-09 1H2N 1 VERSN REVDAT 3 24-FEB-09 1H2N 1 VERSN REVDAT 2 30-JAN-03 1H2N 1 JRNL REVDAT 1 28-NOV-02 1H2N 0 JRNL AUTH J.M.ELKINS,K.S.HEWITSON,L.A.MCNEILL,J.F.SEIBEL, JRNL AUTH 2 I.SCHLEMMINGER,C.PUGH,P.RATCLIFFE,C.J.SCHOFIELD JRNL TITL STRUCTURE OF FACTOR-INHIBITING HYPOXIA-INDUCIBLE FACTOR JRNL TITL 2 (HIF) REVEALS MECHANISM OF OXIDATIVE MODIFICATION OF JRNL TITL 3 HIF-1ALPHA JRNL REF J.BIOL.CHEM. V. 278 1802 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12446723 JRNL DOI 10.1074/JBC.C200644200 REMARK 2 REMARK 2 RESOLUTION. 2.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.0 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 12577 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1046 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.84 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.91 REMARK 3 REFLECTION IN BIN (WORKING SET) : 828 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2860 REMARK 3 BIN FREE R VALUE SET COUNT : 81 REMARK 3 BIN FREE R VALUE : 0.3150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2689 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.02000 REMARK 3 B22 (A**2) : -1.02000 REMARK 3 B33 (A**2) : 2.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.852 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.349 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.398 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.679 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.913 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2791 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2388 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3799 ; 1.628 ; 1.945 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5576 ; 0.823 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 330 ; 4.268 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 479 ;18.082 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 384 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3137 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 575 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 717 ; 0.255 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2425 ; 0.224 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 165 ; 0.139 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): 1 ; 0.102 ; 0.500 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 3 ; 0.112 ; 0.500 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.256 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 62 ; 0.273 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.214 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): 1 ; 0.061 ; 0.500 REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1659 ; 0.312 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2675 ; 0.598 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1132 ; 1.058 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1124 ; 1.795 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 15 A 452 REMARK 3 ORIGIN FOR THE GROUP (A): 21.4490 27.4200 27.7870 REMARK 3 T TENSOR REMARK 3 T11: 0.2230 T22: 0.0562 REMARK 3 T33: 0.0967 T12: 0.0111 REMARK 3 T13: -0.0923 T23: 0.0525 REMARK 3 L TENSOR REMARK 3 L11: 1.6842 L22: 4.4489 REMARK 3 L33: 2.0658 L12: 1.5597 REMARK 3 L13: 1.1572 L23: 2.3523 REMARK 3 S TENSOR REMARK 3 S11: 0.1098 S12: -0.2106 S13: -0.0766 REMARK 3 S21: 0.3449 S22: -0.0455 S23: 0.2455 REMARK 3 S31: 0.3515 S32: -0.1199 S33: -0.0643 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SEE REMARK 400 REMARK 4 REMARK 4 1H2N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-AUG-02. REMARK 100 THE DEPOSITION ID IS D_1290011174. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.5 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13703 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 34.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.30900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: SEE REMARK 400 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2M AMMONIUM SULPHATE, 4% PEG400, REMARK 280 0.1M HEPES PH7.5 ARGON ATMOSPHERE, 11MG/ML PROTEIN WITH 1MM REMARK 280 FE(II), 2.5MM AKG AND 2.5MM PEPTIDE (SEE REMARK 400), PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.36600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.17100 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.17100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.68300 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.17100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.17100 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 110.04900 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.17100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.17100 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.68300 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.17100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.17100 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 110.04900 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.36600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE PROTEIN IS A DIMER FORMED BY CHAIN A. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -131.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 86.34200 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 86.34200 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.36600 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE PROTEIN (CHAIN A) WAS CRYSTALLIZED IN THE PRESENCE REMARK 400 OF A PEPTIDE FRAGEMENT FROM ENDOTHELIAL PAS DOMAIN PROTEIN 1 REMARK 400 SWISS-PROT ID Q99814 (RESIDUES 846-858) BUT NONE OF THE REMARK 400 RESIDUES CORRESPONDING TO THE PEPTIDE WERE VISIBLE IN THE REMARK 400 ELECTRON DENSITY MAPS. IT IS POSSIBLE THAT THE PEPTIDE DID REMARK 400 NOT BIND TO THE PROTEIN AND HENCE HAS NOT BEEN INCLUDED IN THE REMARK 400 COMPND, SOURCE AND SEQRES RECORDS. REMARK 400 REMARK 400 THE SEQUENCE OF THE FRAGMENT IS GIVEN BELOW. REMARK 400 REMARK 400 VAL ASN VAL PRO VAL LEU GLY SER SER THR LEU LEU GLN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 GLU A 7 REMARK 465 ALA A 8 REMARK 465 VAL A 9 REMARK 465 ALA A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 SER A 13 REMARK 465 GLY A 14 REMARK 465 LYS A 304 REMARK 465 ARG A 305 REMARK 465 ILE A 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 15 CG CD OE1 OE2 REMARK 470 GLU A 29 CG CD OE1 OE2 REMARK 470 ASN A 87 CG OD1 ND2 REMARK 470 LYS A 106 CD CE NZ REMARK 470 LYS A 115 CG CD CE NZ REMARK 470 ARG A 117 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 133 CG CD OE1 NE2 REMARK 470 GLN A 136 CG CD OE1 NE2 REMARK 470 GLN A 137 CG CD OE1 NE2 REMARK 470 ARG A 156 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 157 CD CE NZ REMARK 470 LYS A 311 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 39 OE1 GLU A 262 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 134 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 201 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG A 347 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 202 30.22 -88.93 REMARK 500 TYR A 228 72.29 49.88 REMARK 500 ARG A 238 -8.54 84.37 REMARK 500 ASN A 246 76.10 -150.15 REMARK 500 TYR A 276 -10.03 76.69 REMARK 500 ASN A 332 113.58 -161.08 REMARK 500 ARG A 347 -50.12 -126.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FE2 A1350 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 199 NE2 REMARK 620 2 ASP A 201 OD2 106.1 REMARK 620 3 HIS A 279 NE2 77.8 85.5 REMARK 620 4 AKG A1351 O1 168.0 81.1 93.4 REMARK 620 5 AKG A1351 O5 88.7 163.3 90.2 83.1 REMARK 620 N 1 2 3 4 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FE2 A 1350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1352 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1353 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1354 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AKG A 1351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H2K RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1H2L RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1H2M RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE DBREF 1H2N A 1 349 UNP Q9NWT6 HIF1N_HUMAN 1 349 SEQRES 1 A 349 MET ALA ALA THR ALA ALA GLU ALA VAL ALA SER GLY SER SEQRES 2 A 349 GLY GLU PRO ARG GLU GLU ALA GLY ALA LEU GLY PRO ALA SEQRES 3 A 349 TRP ASP GLU SER GLN LEU ARG SER TYR SER PHE PRO THR SEQRES 4 A 349 ARG PRO ILE PRO ARG LEU SER GLN SER ASP PRO ARG ALA SEQRES 5 A 349 GLU GLU LEU ILE GLU ASN GLU GLU PRO VAL VAL LEU THR SEQRES 6 A 349 ASP THR ASN LEU VAL TYR PRO ALA LEU LYS TRP ASP LEU SEQRES 7 A 349 GLU TYR LEU GLN GLU ASN ILE GLY ASN GLY ASP PHE SER SEQRES 8 A 349 VAL TYR SER ALA SER THR HIS LYS PHE LEU TYR TYR ASP SEQRES 9 A 349 GLU LYS LYS MET ALA ASN PHE GLN ASN PHE LYS PRO ARG SEQRES 10 A 349 SER ASN ARG GLU GLU MET LYS PHE HIS GLU PHE VAL GLU SEQRES 11 A 349 LYS LEU GLN ASP ILE GLN GLN ARG GLY GLY GLU GLU ARG SEQRES 12 A 349 LEU TYR LEU GLN GLN THR LEU ASN ASP THR VAL GLY ARG SEQRES 13 A 349 LYS ILE VAL MET ASP PHE LEU GLY PHE ASN TRP ASN TRP SEQRES 14 A 349 ILE ASN LYS GLN GLN GLY LYS ARG GLY TRP GLY GLN LEU SEQRES 15 A 349 THR SER ASN LEU LEU LEU ILE GLY MET GLU GLY ASN VAL SEQRES 16 A 349 THR PRO ALA HIS TYR ASP GLU GLN GLN ASN PHE PHE ALA SEQRES 17 A 349 GLN ILE LYS GLY TYR LYS ARG CYS ILE LEU PHE PRO PRO SEQRES 18 A 349 ASP GLN PHE GLU CYS LEU TYR PRO TYR PRO VAL HIS HIS SEQRES 19 A 349 PRO CYS ASP ARG GLN SER GLN VAL ASP PHE ASP ASN PRO SEQRES 20 A 349 ASP TYR GLU ARG PHE PRO ASN PHE GLN ASN VAL VAL GLY SEQRES 21 A 349 TYR GLU THR VAL VAL GLY PRO GLY ASP VAL LEU TYR ILE SEQRES 22 A 349 PRO MET TYR TRP TRP HIS HIS ILE GLU SER LEU LEU ASN SEQRES 23 A 349 GLY GLY ILE THR ILE THR VAL ASN PHE TRP TYR LYS GLY SEQRES 24 A 349 ALA PRO THR PRO LYS ARG ILE GLU TYR PRO LEU LYS ALA SEQRES 25 A 349 HIS GLN LYS VAL ALA ILE MET ARG ASN ILE GLU LYS MET SEQRES 26 A 349 LEU GLY GLU ALA LEU GLY ASN PRO GLN GLU VAL GLY PRO SEQRES 27 A 349 LEU LEU ASN THR MET ILE LYS GLY ARG TYR ASN HET FE2 A1350 1 HET AKG A1351 10 HET SO4 A1352 5 HET SO4 A1353 5 HET SO4 A1354 5 HETNAM FE2 FE (II) ION HETNAM AKG 2-OXOGLUTARIC ACID HETNAM SO4 SULFATE ION FORMUL 2 FE2 FE 2+ FORMUL 3 AKG C5 H6 O5 FORMUL 4 SO4 3(O4 S 2-) FORMUL 7 HOH *3(H2 O) HELIX 1 1 ASP A 28 LEU A 32 5 5 HELIX 2 2 ASP A 49 ASN A 58 1 10 HELIX 3 3 VAL A 70 TRP A 76 5 7 HELIX 4 4 ASP A 77 ILE A 85 1 9 HELIX 5 5 ASP A 104 GLN A 112 5 9 HELIX 6 6 PHE A 125 ARG A 138 1 14 HELIX 7 7 GLY A 155 GLY A 164 1 10 HELIX 8 8 ASN A 166 ARG A 177 1 12 HELIX 9 9 PRO A 220 ASP A 222 5 3 HELIX 10 10 GLN A 223 TYR A 228 1 6 HELIX 11 11 PHE A 252 VAL A 258 5 7 HELIX 12 12 LYS A 311 GLY A 331 1 21 HELIX 13 13 ASN A 332 GLN A 334 5 3 HELIX 14 14 GLU A 335 LYS A 345 1 11 SHEET 1 AA 5 THR A 39 PRO A 41 0 SHEET 2 AA 5 GLY A 260 VAL A 265 1 O GLY A 260 N ARG A 40 SHEET 3 AA 5 LYS A 214 PHE A 219 -1 O LYS A 214 N VAL A 265 SHEET 4 AA 5 TRP A 278 SER A 283 -1 O TRP A 278 N PHE A 219 SHEET 5 AA 5 VAL A 195 HIS A 199 -1 O THR A 196 N ILE A 281 SHEET 1 AB 6 ARG A 44 LEU A 45 0 SHEET 2 AB 6 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 AB 6 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 AB 6 GLN A 203 LYS A 211 -1 O ASN A 205 N ILE A 273 SHEET 5 AB 6 THR A 290 LYS A 298 -1 O ILE A 291 N ILE A 210 SHEET 6 AB 6 LEU A 182 SER A 184 -1 N THR A 183 O TRP A 296 SHEET 1 AC 9 ARG A 44 LEU A 45 0 SHEET 2 AC 9 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 AC 9 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 AC 9 GLN A 203 LYS A 211 -1 O ASN A 205 N ILE A 273 SHEET 5 AC 9 THR A 290 LYS A 298 -1 O ILE A 291 N ILE A 210 SHEET 6 AC 9 LEU A 186 GLY A 190 -1 O LEU A 186 N ASN A 294 SHEET 7 AC 9 ARG A 143 THR A 149 -1 O LEU A 146 N ILE A 189 SHEET 8 AC 9 ASP A 89 ALA A 95 -1 O SER A 91 N GLN A 147 SHEET 9 AC 9 SER A 118 LYS A 124 -1 O ASN A 119 N SER A 94 LINK NE2 HIS A 199 FE FE2 A1350 1555 1555 1.99 LINK OD2 ASP A 201 FE FE2 A1350 1555 1555 1.86 LINK NE2 HIS A 279 FE FE2 A1350 1555 1555 2.07 LINK FE FE2 A1350 O1 AKG A1351 1555 1555 1.79 LINK FE FE2 A1350 O5 AKG A1351 1555 1555 2.25 CISPEP 1 TYR A 308 PRO A 309 0 2.48 SITE 1 AC1 4 HIS A 199 ASP A 201 HIS A 279 AKG A1351 SITE 1 AC2 4 ARG A 138 GLY A 140 GLU A 141 GLU A 142 SITE 1 AC3 5 ARG A 143 GLU A 192 GLY A 193 LEU A 285 SITE 2 AC3 5 ASN A 286 SITE 1 AC4 4 LYS A 107 GLU A 202 ARG A 320 LYS A 324 SITE 1 AC5 14 TYR A 145 LEU A 188 THR A 196 HIS A 199 SITE 2 AC5 14 ASP A 201 ASN A 205 PHE A 207 LYS A 214 SITE 3 AC5 14 HIS A 279 ILE A 281 ASN A 294 TRP A 296 SITE 4 AC5 14 FE2 A1350 HOH A2001 CRYST1 86.342 86.342 146.732 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011582 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011582 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006815 0.00000